Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Section 1013: Request for Nominations-The Effective Health Care Stakeholder Group, 996-997 [E9-31341]
Download as PDF
<![CDATA[
996
Federal Register / Vol. 75, No. 4 / Thursday, January 7, 2010 / Notices
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198,
MSC 7808, Bethesda, MD 20892, 301–435–
2306, boundst@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies; Community-Level Health
Promotion Study Section.
Date: February 4–5, 2010.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Monaco, 495 Geary Street, San
Francisco, CA 94102.
Contact Person: Jacinta Bronte-Tinkew,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3164,
MSC 7770, Bethesda, MD 20892, (301) 435–
1503, brontetinkewjm@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group Adult Psychopathology and Disorders
of Aging Study Section.
Date: February 4–5, 2010.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Ave., NW., Washington, DC 20037.
Contact Person: Estina E. Thompson, PhD,
MPH, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178,
MSC 7848, Bethesda, MD 20892, 301–496–
5749, thompsone@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neurotechnology 2.
Date: February 5, 2010.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin St. Francis, 335 Powell
Street, San Francisco, CA 94102.
Contact Person: Robert C. Elliott, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3130,
MSC 7850, Bethesda, MD 20892, 301–435–
3009, elliotro@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 30, 2009.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–35 Filed 1–6–10; 8:45 am]
BILLING CODE 4140–01–P
VerDate Nov<24>2008
14:42 Jan 06, 2010
Jkt 220001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Medicare Prescription Drug,
Improvement, and Modernization Act
of 2003 Section 1013: Request for
Nominations—The Effective Health
Care Stakeholder Group
AGENCY: Agency for Healthcare Research
and Quality (AHRQ), DHHS.
ACTION: Notice of invitation to submit
nominations for the Effective Health
Care Stakeholder Group.
SUMMARY: The DHHS Agency for
Healthcare Research and Quality
(AHRQ) invites nominations from
interested organizations and
knowledgeable individuals for members
of the Stakeholder Group to support the
work of the Effective Health Care
Program, established [for consultation]
pursuant to Section 1013 of the
Medicare Prescription Drug,
Improvement, and Modernization Act
(MMA) of 2003. The goals of this
program are to develop evidence on the
effectiveness and comparative
effectiveness of different treatments and
health care interventions of importance
to the Medicare, Medicaid, and State
Child Health Insurance programs. To
achieve these goals, AHRQ supports
projects to review, synthesize, generate,
and translate scientific evidence, as well
as identify important issues for which
existing scientific evidence is
insufficient to inform decisions about
health care. The Effective Health Care
Program makes the evidence
information it develops readily available
to health care decision makers. The
Stakeholder Group is critical to the
success of the Effective Health Care
Program by providing input to improve
the applicability and relevance of
research products to health care
decision makers. The Effective Health
Care Program Stakeholder Group will be
a part of the Citizen’s Forum initiative,
funded by the American Recovery and
Reinvestment Act, to formally and
broadly engage stakeholders, and to
enhance and expand public
involvement in the entire Effective
Health Care enterprise.
The role of the Stakeholder Group will
be to:
• Provide guidance on program
implementation including:
i. Quality improvement.
ii. Opportunities to maximize impact
and expand program reach.
iii. Ensuring stakeholder interests are
considered and included.
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
iv. Evaluating success.
• Provide input on implementing
Effective Health Care Program reports
and findings in practice and policy
settings.
• Identify options and recommend
solutions to issues identified by
Effective Health Care Program staff.
• Provide input on critical research
information gaps for practice and
policy, as well as research methods to
address them. Specifically:
i. Information needs and types of
products most useful to consumers,
clinicians and policy makers.
ii. Feedback on Effective Health Care
Program reports, reviews and summary
guides.
iii. Scientific methods and
applications.
• Champion objectivity,
accountability and transparency in the
Effective Health Care program.
Members will serve as volunteers for
a two-year period from summer 2010
through summer 2012. Stakeholder
Group members will attend 3–4
meetings per year in Rockville, MD, and
possibly other cities to be determined.
Meetings will be 1–2 days in length, and
AHRQ or a group designated by AHRQ
will be responsible for travel planning
and expenses. The first meeting will be
held in late summer or early fall 2010
in Rockville, MD.
Members are expected to actively
participate in meetings and to engage in
related activities by phone and e-mail
between meetings. Between-meeting
work may include reviewing and
providing input on the overall product
development strategy and direction for
the Effective Health care program,
consulting with AHRQ staff on
constituency issues, and serving as a
resource to the Program. It is anticipated
that the Stakeholder Group member
time commitment between meetings
will not exceed 10 hours.
The Stakeholder Group will be
composed of up to 20 members with a
diversity of perspectives and opinions.
The group will represent several broad
constituencies of stakeholders and
decision-makers at the policy, system,
and clinical levels, which will include:
• Patient/caregiver/consumer.
• Consumers of Federal and State
beneficiary programs.
• Healthcare providers.
• Third party healthcare payers
(including, but not limited to public
State or Federal Medicare or Medicaid
programs, and private insurance health
plans and Health Maintenance
Organizations).
• Employers and health-related
businesses.
• Pharmacy and therapeutic
committees.
E:\FR\FM\07JAN1.SGM
07JAN1
Federal Register / Vol. 75, No. 4 / Thursday, January 7, 2010 / Notices
• Healthcare, industry, and
professional organizations.
• Academic researchers (including,
but not limited to, those with expertise
in evidence-based methods and
effectiveness and translational research).
Self-nominations are encouraged.
Materials to be submitted include a
cover letter and curriculum vitae or
similar supportive documentation. The
cover letter should provide information
on how the nominee’s experience, skills
and roles would help to reflect the
diverse perspectives and expertise of the
group and help to address the functions
and goals of the Stakeholder Group as
described above. Specific information
on nominee experience in the
constituency groups described above is
required. If nominating a second party,
a statement of the nominee’s permission
and willingness to serve must be
provided. Nominees chosen for the
Stakeholder Group will be required to
declare and submit conflict of interest
documentation. Nominees may indicate
their willingness to be considered in
subsequent calls for nominations if not
selected for this Stakeholder Group.
All nominations received by the
submission deadline will be reviewed
by a committee composed of
representatives from AHRQ. Nominees
who best represent the broad
constituencies sought for composition of
the Stakeholder Group as described
above, will be selected and notified by
May 7, 2010.
DATES: Nominations for the Effective
Health Care Stakeholder Group must be
received by February 8, 2010.
Nominations for
consideration may be e-mailed to
EffectiveHealthCare@AHRQ.gov.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Effective Health Care Program at (301)
427–1502 or
EffectiveHealthCare@AHRQ.gov.
More information about the Effective
Health Care Program is available at
https://www.EffectiveHealthCare.
AHRQ.gov.
Nominees
not selected for the Stakeholder Group
are invited to participate in the Effective
Healthcare Program by making
suggestions for research and providing
comment on key questions and draft
reviews. A listserv has been established
and everyone interested may join to be
notified when items become available
for review or public comment.
Opportunities for involvement in the
Effective Health Care Program are
described at https://
www.EffectiveHealthCare.AHRQ.gov.
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Nov<24>2008
14:42 Jan 06, 2010
Jkt 220001
Dated: December 22, 2009.
Carolyn M. Clancy,
Director.
[FR Doc. E9–31341 Filed 1–6–10; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2007–28460]
Record of Decision (ROD) on the U.S.
Coast Guard Long Range Aids to
Navigation (Loran-C) Program
Coast Guard, DHS.
Notice of availability.
AGENCY:
ACTION:
SUMMARY: The Department of Homeland
Security (DHS), United States Coast
Guard (USCG), announces the
availability of the Record of Decision
(ROD) to decommission the USCG
Loran-C Program and terminate
transmission of the North American
Loran-C Radionavigation Signal. The
ROD is supported by the Final
Programmatic Environmental Impact
Statement (PEIS) addressing the future
of the USCG Loran-C Program. The
Final PEIS availability was announced
by the Environmental Protection Agency
(EPA) on June 12, 2009 (74 FR 28046).
DATES: The Final PEIS and ROD are now
available in the docket. The USCG
intends to begin termination of the
broadcast of the North American LoranC Radionavigation Signal beginning on
or about February 8, 2010. Loran
stations are expected to cease
transmitting the Loran-C
radionavigation signal by October 1,
2010.
ADDRESSES: To view the ROD or the
Final PEIS, go to https://
www.regulations.gov, insert USCG–
2007–28460 in the ‘‘Keyword’’ box, and
then click ‘‘Search.’’ Project documents,
including the Final PEIS, are also
available on the ‘‘USCG Long Range
Aids to Navigation (Loran-C) Program’’
Web site at https://loranpeis.uscg.e2minc.com/. If access to the Internet is not
available, you may view the docket
online by visiting the Docket
Management Facility in Room W12–140
on the ground floor of the Department
of Transportation West Building, 1200
New Jersey Avenue, SE., Washington,
DC 20590, between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal
holidays.
FOR FURTHER INFORMATION CONTACT: If
there are questions on this notice, call
LCDR Robert Manning, Electronic
Navigation Division, USCG, telephone
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
997
202–372–1560, or e-mail
robert.j.manning@uscg.mil. If you have
questions on viewing or submitting
material to the docket, call Renee V.
Wright, Program Manager, Docket
Operations, telephone 202–366–9826.
Background and Purpose
Loran is a radionavigation system first
developed during World War II and
operated by the USCG. The current
Loran-C system is a low frequency
hyperbolic radionavigation system
approved for use in the Coastal
Confluence Zone and as a supplemental
air navigation aid. The Loran-C
radionavigation system provides
navigation, location, and timing services
for both civil and military air, land, and
marine users in the continental United
States (CONUS) and Alaska. The USCG
operates 18 CONUS Loran Stations, 6
Alaska Loran Stations, and 24
monitoring sites.
On January 22, 2009 (74 FR 4047), the
USCG made available the Draft PEIS.
The USCG delivered the Final PEIS
addressing the future of the USCG
Loran-C Program to the EPA, and the
EPA announced the availability of the
Final PEIS on June 12, 2009 (74 FR
28046).
By separate notice published today in
the Federal Register, the USCG advised
the public of the USCG’s intention to
begin planning for the termination of
the broadcast of the North American
Loran-C Radionavigation Signal
beginning on or about February 8, 2010.
The USCG advised that if plans were
implemented, Loran stations would
cease transmitting the Loran-C
radionavigation signal by October 1,
2010.
The Final PEIS on the future of the
USCG Loran-C Program is a programlevel document that provided the USCG
with high-level analysis of the potential
impacts on the human environment
from the alternatives for the future of
the USCG Loran-C Program. The Final
PEIS evaluated the following five
alternatives on the future of the USCG
Loran-C Program:
(1) No Action Alternative. The No
Action Alternative refers to the current,
existing conditions without
implementation of the Proposed Action.
(2) Decommission the USCG Loran-C
Program and Terminate the North
American Loran-C Radionavigation
Signal.
(3) Automate, Secure, and Unstaff
Loran-C Stations.
(4) Automate, Secure, Unstaff, and
Transfer Management of the Loran-C
Program to Another Government
Agency.
E:\FR\FM\07JAN1.SGM
07JAN1
]]>Agencies
[Federal Register Volume 75, Number 4 (Thursday, January 7, 2010)]
[Notices]
[Pages 996-997]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-31341]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Medicare Prescription Drug, Improvement, and Modernization Act of
2003 Section 1013: Request for Nominations--The Effective Health Care
Stakeholder Group
AGENCY: Agency for Healthcare Research and Quality (AHRQ), DHHS.
ACTION: Notice of invitation to submit nominations for the Effective
Health Care Stakeholder Group.
-----------------------------------------------------------------------
SUMMARY: The DHHS Agency for Healthcare Research and Quality (AHRQ)
invites nominations from interested organizations and knowledgeable
individuals for members of the Stakeholder Group to support the work of
the Effective Health Care Program, established [for consultation]
pursuant to Section 1013 of the Medicare Prescription Drug,
Improvement, and Modernization Act (MMA) of 2003. The goals of this
program are to develop evidence on the effectiveness and comparative
effectiveness of different treatments and health care interventions of
importance to the Medicare, Medicaid, and State Child Health Insurance
programs. To achieve these goals, AHRQ supports projects to review,
synthesize, generate, and translate scientific evidence, as well as
identify important issues for which existing scientific evidence is
insufficient to inform decisions about health care. The Effective
Health Care Program makes the evidence information it develops readily
available to health care decision makers. The Stakeholder Group is
critical to the success of the Effective Health Care Program by
providing input to improve the applicability and relevance of research
products to health care decision makers. The Effective Health Care
Program Stakeholder Group will be a part of the Citizen's Forum
initiative, funded by the American Recovery and Reinvestment Act, to
formally and broadly engage stakeholders, and to enhance and expand
public involvement in the entire Effective Health Care enterprise.
The role of the Stakeholder Group will be to:
Provide guidance on program implementation including:
i. Quality improvement.
ii. Opportunities to maximize impact and expand program reach.
iii. Ensuring stakeholder interests are considered and included.
iv. Evaluating success.
Provide input on implementing Effective Health Care
Program reports and findings in practice and policy settings.
Identify options and recommend solutions to issues
identified by Effective Health Care Program staff.
Provide input on critical research information gaps for
practice and policy, as well as research methods to address them.
Specifically:
i. Information needs and types of products most useful to
consumers, clinicians and policy makers.
ii. Feedback on Effective Health Care Program reports, reviews and
summary guides.
iii. Scientific methods and applications.
Champion objectivity, accountability and transparency in
the Effective Health Care program.
Members will serve as volunteers for a two-year period from summer
2010 through summer 2012. Stakeholder Group members will attend 3-4
meetings per year in Rockville, MD, and possibly other cities to be
determined. Meetings will be 1-2 days in length, and AHRQ or a group
designated by AHRQ will be responsible for travel planning and
expenses. The first meeting will be held in late summer or early fall
2010 in Rockville, MD.
Members are expected to actively participate in meetings and to
engage in related activities by phone and e-mail between meetings.
Between-meeting work may include reviewing and providing input on the
overall product development strategy and direction for the Effective
Health care program, consulting with AHRQ staff on constituency issues,
and serving as a resource to the Program. It is anticipated that the
Stakeholder Group member time commitment between meetings will not
exceed 10 hours.
The Stakeholder Group will be composed of up to 20 members with a
diversity of perspectives and opinions. The group will represent
several broad constituencies of stakeholders and decision-makers at the
policy, system, and clinical levels, which will include:
Patient/caregiver/consumer.
Consumers of Federal and State beneficiary programs.
Healthcare providers.
Third party healthcare payers (including, but not limited
to public State or Federal Medicare or Medicaid programs, and private
insurance health plans and Health Maintenance Organizations).
Employers and health-related businesses.
Pharmacy and therapeutic committees.
[[Page 997]]
Healthcare, industry, and professional organizations.
Academic researchers (including, but not limited to, those
with expertise in evidence-based methods and effectiveness and
translational research).
Self-nominations are encouraged. Materials to be submitted include
a cover letter and curriculum vitae or similar supportive
documentation. The cover letter should provide information on how the
nominee's experience, skills and roles would help to reflect the
diverse perspectives and expertise of the group and help to address the
functions and goals of the Stakeholder Group as described above.
Specific information on nominee experience in the constituency groups
described above is required. If nominating a second party, a statement
of the nominee's permission and willingness to serve must be provided.
Nominees chosen for the Stakeholder Group will be required to declare
and submit conflict of interest documentation. Nominees may indicate
their willingness to be considered in subsequent calls for nominations
if not selected for this Stakeholder Group.
All nominations received by the submission deadline will be
reviewed by a committee composed of representatives from AHRQ. Nominees
who best represent the broad constituencies sought for composition of
the Stakeholder Group as described above, will be selected and notified
by May 7, 2010.
DATES: Nominations for the Effective Health Care Stakeholder Group must
be received by February 8, 2010.
ADDRESSES: Nominations for consideration may be e-mailed to
EffectiveHealthCare@AHRQ.gov.
FOR FURTHER INFORMATION CONTACT: Effective Health Care Program at (301)
427-1502 or EffectiveHealthCare@AHRQ.gov.
More information about the Effective Health Care Program is
available at https://www.EffectiveHealthCare.AHRQ.gov.
SUPPLEMENTARY INFORMATION: Nominees not selected for the Stakeholder
Group are invited to participate in the Effective Healthcare Program by
making suggestions for research and providing comment on key questions
and draft reviews. A listserv has been established and everyone
interested may join to be notified when items become available for
review or public comment. Opportunities for involvement in the
Effective Health Care Program are described at https://www.EffectiveHealthCare.AHRQ.gov.
Dated: December 22, 2009.
Carolyn M. Clancy,
Director.
[FR Doc. E9-31341 Filed 1-6-10; 8:45 am]
BILLING CODE 4160-90-M
